2026

1. Bacteria outer membrane-based oxygen gels alleviate tumor hypoxia for enhanced systemic immune response to radiotherapy
2. Biomineralized Zn2+-siRNA complex enhances CD47 blockade therapy by facilitating phagocytosis and mtDNA sensing.
3. Thymidine-Auxotrophic Salmonella Enables Selective Tumor Colonization and Adenosine Depletion for Cancer Immunotherapy.
4. Recent advances in microbial biohybrids based oxygen delivery systems.

2025

1. In situ enrichment and delivery of STING agonists by protamine-modified Salmonella for cancer immunotherapy
2. Recent advances in intelligent oxygen delivery systems for tissue regeneration
3. Protein-based embolic agent loaded with ethiodized oil for targeted tumor vascular embolization
4. Combretastatin A4-Based Albumin Nanoparticles Remodeling the Tumor Immune Microenvironment to Enhance T Cell Immunotherapy in Colon Cancer
5. Orthogonally Engineered Bacteria Capture Metabolically Labeled Tumor Antigens to Improve the Systemic Immune Response in Irradiated Tumors

2024

1. In Situ Aggregated Nanomanganese Enhances Radiation-Induced Antitumor Immunity
2. Novel Photo-STING Agonists Delivered by Erythrocyte Efferocytosis-Mimicking Pattern to Repolarize Tumor-Associated Macrophages for Boosting Anticancer Immunotherapy

2023

1. Antigen-loaded flagellate bacteria for enhanced adaptive immune response by intradermal injection
2. Phase-Change Based Oxygen Carriers Improve Acute Cerebral Hypoxia
3. Novel emerging nano-assisted anti-cancer strategies based on the STING pathway